VOLITIONRX LTD — Director's Dealing 2020

Apr 15, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2020-04-13

Reporting Person: Kway Jasmine (CEO-Singapore Volition)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-04-13	Stock Option (Right to Buy)	$3.6	A	55000	Acquired	2026-04-13	Common Stock (55000)	Direct

Footnotes

F1: A total of 55,000 Options were granted on April 13, 2020 under the Company's 2015 Stock Incentive Plan. The Options vest in full twelve months from the date of grant.